Religare's research report on ColgateCLGT posted below-expected topline growth of 1.8% YoY for Q3FY16 as volume growth disappointed at 1% YoY. Organic growth however was higher at 7% YoY adjusting for lower excise benefits. EBITDA/adj. PAT grew 19.1%/7.6% YoY as a cut in A&P spends buoyed margins to 22.2% (RCMLe: 21.8%). We pare our EPS estimates to build in lower topline growth and roll over to a Mar’17 TP of Rs 1,080 (Sep’16 TP of Rs 1,100). Valuations at 33x/28x FY17/FY18 earnings are attractive. Maintain BUY.We pare our FY16-FY18 EPS by 4-9% in view of the lower sales growth than envisaged earlier. However, we maintain our BUY rating on attractive valuations of 33x/28 FY17/FY18 and roll over to a Mar’17 TP of Rs 1,080 (from a Sep’16 TP of Rs 1,100).For all recommendations, click here Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
Read More
